Cargando…
Stability of peripheral blood immune markers in patients with asthma
BACKGROUND: Asthma is a complex disease with variable course. Efforts to identify biomarkers to predict asthma severity, the course of disease and response to treatment have not been very successful so far. We have previous suggested that PAR-2 and CRTh2 expression on specific peripheral blood cell...
Autores principales: | Shrestha Palikhe, Nami, Bosonea, Ana-Maria, Laratta, Cheryl, Gandhi, Vivek Dipak, Nahirney, Drew, Hillaby, Angela, Bowen, Miranda, Bhutani, Mohit, Mayers, Irvin, Cameron, Lisa, Vliagoftis, Harissios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489239/ https://www.ncbi.nlm.nih.gov/pubmed/31168305 http://dx.doi.org/10.1186/s13223-019-0343-4 |
Ejemplares similares
-
Increased Protease-Activated Receptor-2 (PAR-2) Expression on CD14(++)CD16(+) Peripheral Blood Monocytes of Patients with Severe Asthma
por: Shrestha Palikhe, Nami, et al.
Publicado: (2015) -
Proteinase-activated receptor-2 (PAR-2) expression on inflammatory cells in severe asthma
por: Nahirney, Drew, et al.
Publicado: (2014) -
Protease-activated receptor-2: Role in asthma pathogenesis and utility as a biomarker of disease severity
por: Gandhi, Vivek Dipak, et al.
Publicado: (2022) -
Growth factors regulate proteinase activated receptor – 2 (PAR-2) on airway epithelium
por: Gandhi, Vivek, et al.
Publicado: (2014) -
The CRTh2 polymorphism rs533116 G > A associates with asthma severity in older females
por: Shrestha Palikhe, Nami, et al.
Publicado: (2022)